T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma

References

1. 1.↵
   1. Ryall S,
   2. Tabori U,
   3. Hawkins C

   . Pediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol Commun 2020;8:30 doi:10.1186/s40478-020-00902-z pmid:32164789

   CrossRefPubMed
2. 2.↵
   1. Ostrom QT,
   2. Gittleman H,
   3. Liao P, et al

   . CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol 2017;19:v1–88 doi:10.1093/neuonc/nox158 pmid:29117289

   CrossRefPubMed
3. 3.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
4. 4.↵
   1. Ryall S,
   2. Zapotocky M,
   3. Fukuoka K, et al

   . Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell 2020;37:569–83.e5 doi:10.1016/j.ccell.2020.03.011 pmid:32289278

   CrossRefPubMed
5. 5.↵
   1. Packer RJ,
   2. Pfister S,
   3. Bouffet E, et al

   . Pediatric low-grade gliomas: implications of the biologic era. Neuro Oncol 2017;19:750–61 doi:10.1093/neuonc/now209 pmid:27683733

   CrossRefPubMed
6. 6.↵
   1. AlRayahi J,
   2. Zapotocky M,
   3. Ramaswamy V, et al

   . Pediatric brain tumor genetics: what radiologists need to know. Radiographics 2018;38:2102–22 doi:10.1148/rg.2018180109 pmid:30422762

   CrossRefPubMed
7. 7.↵
   1. Patel SH,
   2. Poisson LM,
   3. Brat DJ, et al

   . T2-FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project. Clin Cancer Res 2017;23:6078–85 doi:10.1158/1078-0432.CCR-17-0560 pmid:28751449

   Abstract/FREE Full Text
8. 8.↵
   1. Johnson DR,
   2. Kaufmann TJ,
   3. Patel SH, et al

   . There is an exception to every rule-T2-FLAIR mismatch sign in gliomas. Neuroradiology 2019;61:225–27 doi:10.1007/s00234-018-2148-4 pmid:30565056

   CrossRefPubMed
9. 9.↵
   1. Louis DN,
   2. Perry A,
   3. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
10. 10.↵
    1. Jain R,
    2. Johnson DR,
    3. Patel SH, et al

    . “Real world” use of a highly reliable imaging sign: “T2-FLAIR mismatch” for identification of IDH mutant astrocytomas. Neuro Oncol 2020;22:936–43 doi:10.1093/neuonc/noaa041 pmid:32064507

    CrossRefPubMed
11. 11.↵
    1. Do YA,
    2. Cho SJ,
    3. Choi BS, et al

    . Predictive accuracy of T2-FLAIR mismatch sign for the IDH-mutant, 1p/19q noncodeleted low-grade glioma: an updated systematic review and meta-analysis. Neurooncol Adv 2022;4:vdac010 doi:10.1093/noajnl/vdac010 pmid:35198981

    CrossRefPubMed
12. 12.↵
    1. Kalelioglu T,
    2. Rama B,
    3. Cho BB, et al

    . Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases. Neuroradiol J 2023;36:232–35 doi:10.1177/19714009221126015 pmid:36074655

    CrossRefPubMed
13. 13.↵
    1. Chiang J,
    2. Harreld JH,
    3. Tinkle CL, et al

    . A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. Acta Neuropathol 2019;138:1091–92 doi:10.1007/s00401-019-02081-1 pmid:31595312

    CrossRefPubMed
14. 14.↵
    1. Tay KL,
    2. Tsui A,
    3. Phal PM, et al

    . MR imaging characteristics of protoplasmic astrocytomas. Neuroradiology 2011;53:405–11 doi:10.1007/s00234-010-0741-2 pmid:20644924

    CrossRefPubMed
15. 15.↵
    1. Deguchi S,
    2. Oishi T,
    3. Mitsuya K, et al

    . Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas. Sci Rep 2020;10:10113 doi:10.1038/s41598-020-67244-7 pmid:32572107

    CrossRefPubMed
16. 16.↵
    1. Fujita Y,
    2. Nagashima H,
    3. Tanaka K, et al

    . The histopathologic and radiologic features of T2-FLAIR mismatch sign in IDH-mutant 1p/19q non-codeleted astrocytomas. World Neurosurg 2021;149:e253–60 doi:10.1016/j.wneu.2021.02.042 pmid:33610870

    CrossRefPubMed
17. 17.↵
    1. Kinoshita M,
    2. Uchikoshi M,
    3. Sakai M, et al

    . T₂-FLAIR mismatch sign is caused by long T₁ and T₂ of IDH-mutant, 1p19q non-codeleted astrocytoma. Magn Reson Med Sci 2021;20:119–23 doi:10.2463/mrms.bc.2019-0196 pmid:32101817

    CrossRefPubMed
18. 18.↵
    1. Suh YL

    . Dysembryoplastic neuroepithelial tumors. J Pathol Transl Med 2015;49:438–49 doi:10.4132/jptm.2015.10.05 pmid:26493957

    CrossRefPubMed